OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
June 4, 2026
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
Category
June 4, 2026
OncLive: HERTHENA-Breast04 Is Set to Delineate the Role of HER3-Targeted Therapy in Advanced HR+ Breast Cancer
June 4, 2026
MedPage Today: Accumulating Evidence Lifts GLP-1s to Clinical Trial for Breast Cancer Prevention
June 4, 2026
Becker’s Dental + DSO Review: DSOs, dental schools and companies secure $270M in funding boons
June 4, 2026
Healio: HemOnc Today announces 2026 Disruptive Innovators
June 4, 2026
The New York Times: Raising Dementia Awareness, One Black Church at a Time
June 4, 2026
San Antonio Report: UT San Antonio lands millions in new state funding